FEATURES
It’s not uncommon for investors to manage money for family and friends, but both sides need to consider the risks of mismanagement and abuse and how they can prevented, write Rosie Carr.
Finding the cure: autoimmune illnesses
There are currently more than 300 potential autoimmune drugs in the clinical stage of development, but do any of them hold the key to curing these ferocious illnesses?
Diversification – different this time?
John Baron questions accepted norms and explains the investment trust portfolios’ approach
SEVEN DAYS
Our take on the biggest business stories of the past week
NEWS
Sainsbury/Asda and Tesco – a duopoly in the making?
Aviva woos investors with compensation and buybacks
Exclusive: Polymetal looks beyond precious metals to rare earths
Apple’s record figures silence doubters
Inmarsat rallies on results relief
Paddy Power disappoints in first quarter
Rising tide lifts Shell and BP
News Spotlight – UK blue chips become hot property
Economic Outlook – Rates damage, Next week’s economics
COMMENT
The Editor – In the money?
Simon Thompson – Five small caps with Character
Mr Bearbull – It Asda be done
Chris Dillow – Worrying about bonds, Against evidence-based investing
The Trader – European banking union
YOUR MONEY
Portfolio Clinic – Beware having a false sense of security
TIPS
Buy under-rated Moneysupermarket
Dotdigital: subscribe for growth
Genel Energy: autonomous drive
Buy into well valued Marlborough European Multi-Cap
Tips Updates
FUNDS
Nigel Thomas to quit AXA Framlington Select Opps
Does your investment trust have skin in the game
The UK is a treasure trove for value investors
SHARES
Taking Stock – Keeping abreast of the ‘churn’
Sector Focus – UK Banks: capital strength defies inconsistent returns
Results
TAKEOVERS
Abcam surprises with Horizon bid
DIRECTORS DEALINGS
Capita managers make grand gesture
Purplebricks directors cash in
